Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zepbound Tops Wegovy for Weight Loss
Eli Lilly’s Weight-Loss Drug Zepbound More Effective than Novo’s Wegovy, Study Shows
New data indicating Eli Lilly’s obesity shot Zepbound works better than Novo Nordisk’s Wegovy could add fuel to Lilly’s new efforts to market the drug as shortages ease.Recent months have brought new questions about whether the sky-high expectations for Zepbound’s sales—which have sent Lilly’s share price up more than 230% over the past three years—may be overly optimistic.
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
Yahoo Finance
3h
The Weight Loss Drug Race Heats Up: Eli Lilly's Zepbound Outperforms Wegovy in Weight Loss Trials
Eli
Lilly
(NYSE:LLY) has been making headlines recently with its weight-loss drug
Zepbound
(tirzepatide).
Eli
Lilly
...
3d
Eli Lilly’s Growth Driven by Strong Prescription Trends for Mounjaro and Zepbound
Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and increased the price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
French government falls
Fox News commentator dies
Congress halts Ukraine aid
May cut diabetes risk
Warns iPhone, Android users
Denied place on ballot
Recuses himself from case
US telecom firms hacked
Independent run for gov.
Leaded gas health risk
Rock band robbed in CA
Theriault ends recount
Rockefeller tree lights up
MX record fentanyl bust
DOJ: Bias against Blacks
Medellin cartel leader freed
Tops $100K for the first time
Sun hire new head coach
Atkins tapped as SEC chair
Recalls over 205,000 SUVs
Private payrolls grew 146K
Students' math skills decline
Composer Laird dies at 85
Taiwan's pres visits Guam
Raw milk recall expands
$10B AI data center in LA
Weekly jobless claims rise
DC AG sues Amazon
California school shooting
Asteroid nearly hits Earth
Picked to head NASA
Related topics
Wegovy
Novo Nordisk
Amgen
Feedback